ArticleDrugs - real world outcomes2018

Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs.

Rosarin Sruamsiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.